WIKI4 is a novel tankyrase inhibitor with an IC50 of 15 nM against TNKS2; it inhibits the Wnt/β-catenin signaling pathway in various cancer cell lines, including A375, DLD1 colorectal cancer, NALM6B, U2OS osteosarcoma, and human embryonic stem cells (hESCs); it stabilizes AXIN1 and other β-catenin destruction complex components by inhibiting tankyrase-mediated poly(ADP-ribosyl)ation, thereby preventing ubiquitination and proteasomal degradation of AXIN proteins.